Get the latest Science News and Discoveries

This new semaglutide dose helped nearly half of patients lose 20% body weight


The STEP UP trials revealed that a 7.2 mg dose of semaglutide led to greater weight loss than the currently approved 2.4 mg dose. Nearly half of participants lost 20% or more of their body weight, while also improving metabolic health. Side effects were mostly mild and temporary. Researchers say this could reshape obesity treatment if confirmed in longer-term studies.

None

Get the Android app

Or read this on ScienceDaily

Read more on:

Photo of patients

patients

Photo of half

half

Photo of % body weight

% body weight

Related news:

News photo

Removing these 50 objects from orbit would cut danger from space junk in half

News photo

Virtual reality can reduce anxiety in patients undergoing interventional cardiovascular procedure - EurekAlert!

News photo

New study led by University Hospitals Connor Whole Health shows chiropractic care associated with reduction in opioid use disorder in patients with low back pain - EurekAlert!